| 000 -LEADER |
|---|
| fixed length control field |
07687cam a22003974a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20190905141538.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
080919s2008 maua b 101 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781573317337 |
|
|---|
| International Standard Book Number |
1573317330 |
| 041 ## - Language |
|---|
| Language code of text/sound track or separate title |
eng |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RC660.A15 |
| Item number |
I46 2008 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.462079 |
| Edition number |
22 |
| Item number |
I46 |
| 110 2# - MAIN ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Immunology of Diabetes Society. |
| Subordinate unit |
International Congress |
| Number of part/section/meeting |
(9th : |
| Date of meeting or treaty signing |
2007 : |
| Location of meeting |
Miami Beach, Fla.) |
| 9 (RLIN) |
4207 |
| 245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
|---|
| Title |
Immunology of diabetes V : |
| Remainder of title |
from bench to bedside / |
| Statement of responsibility, etc |
edited by Carani B. Sanjeevi, Desmond A. Schatz, and Mark A. Atkinson. |
| 246 3# - VARYING FORM OF TITLE |
|---|
| Title proper/short title |
Immunology of diabetes 5 |
|
|---|
| Title proper/short title |
Immunology of diabetes five |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Boston, MA : |
| Name of publisher, distributor, etc |
Published by Blackwell Pub. on behalf of the New York Academy of Sciences, |
| Date of publication, distribution, etc |
2008. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xiii, 330 p. : |
| Other physical details |
ill. (some col.) ; |
| Dimensions |
26 cm. |
| 440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE |
|---|
| 9 (RLIN) |
34 |
| Title |
Annals of the New York Academy of Sciences, |
| International Standard Serial Number |
0077-8923 ; |
| Volume number/sequential designation |
v. 1150 |
| 500 ## - GENERAL NOTE |
|---|
| General note |
"This volume is the result of the 9th International Congress of the Immunology of Diabetes Society and the American Diabetes Association Research Symposium, held on November 14-18, 2007 at the Loews Miami Beach Hotel, Miami Beach, Florida"--P. vii. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
The Environmental Determinants of Diabetes in the Young (TEDDY) Study -- Immunology of diabetes V: from bench to bedside. Proceedings of the 9th International Congress of the Immunology of Diabetes Society. November 14-18, 2007. Miami, Florida, USA -- Type 1 Diabetes TrialNet--an international collaborative clinical trials network -- What will it take to get therapies approved for type 1 diabetes? -- Islet glia, neurons, and beta cells -- Hedgehog signaling during expansion of human pancreatic islet-derived precursors -- Humanized mice for the study of type 1 diabetes and beta cell function -- Developing a novel model system to target insulin-reactive CD8 T cells -- Lowered expressions of the NF-kappaB family members in dendritic cells from NOD mice are associated with a reduced expression of GATA-2 -- Measurement of CD8 T cell responses in human type 1 diabetes -- Comparative analysis of the islet proteome between NOD/Lt and ALR/Lt mice -- MicroRNA genes -- Independent association of tumor necrosis factor polymorphism with type 1 diabetes susceptibility -- HLA class I supertypes in type 1 diabetic children in an urban children's hospital -- Congenic mapping of the MHC-linked susceptibility to type 1 diabetes in the NOD mouse: at least two genes contribute to the Idd16 effect -- STAT4 polymorphism is associated with early-onset type 1 diabetes, but not with late-onset type 1 diabetes -- From Type 1, through LADA, to type 2 diabetes: a continuous spectrum? -- Molecular scanning of the gene for thioredoxin, an antioxidative and antiapoptotic protein, and genetic susceptibility to type 1 diabetes -- Risk conferred by HLA-DR and DQ for type 1 diabetes in 0-35-year age group in Sweden -- Closing the circle between the bedside and the bench: Toll-like receptors in models of virally induced diabetes -- Toll-like receptors and diabetes -- Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations -- Innate immune pathways in virus-induced autoimmune diabetes -- The distribution of adiponectin receptors on human peripheral blood mononuclear cells -- The role of Toll-like receptors 3 and 9 in the development of autoimmune diabetes in NOD mice -- TLR agonists abrogate co-stimulation blockade-induced mixed chimerism and transplantation tolerance -- Exendin-4 therapy in NOD mice with new-onset diabetes increases regulatory T cell frequency -- Role of increased ROS dissipation in prevention of T1D -- Apoptotic non-beta cells suppress beta cell antigen-reactive T cells and induce beta cell antigen-specific regulatory T cells -- Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides. |
|
|---|
| Formatted contents note |
TGFbeta plasmid construction and delivery for the prevention of type 1 diabetes -- Intravenous administration of proinsulin 1 or 2-expressing fiber-mutant recombinant adenovirus vector protects against the development of diabetes in NOD mice -- IFN-alpha can both protect against and promote the development of type 1 diabetes -- Update on worldwide efforts to prevent type 1 diabetes -- Tobacco exposure and diabetes-related autoantibodies in children: results from the ABIS study -- Variations in incidence of type 1 diabetes in different municipalities of stockholm -- Eradication of Helicobactor pylori may trigger onset of type 1 diabetes: a case report -- Diabetogenic effects of the most prevalent enteroviruses in Finnish sewage -- Co-transplantation of stromal cells interferes with the rejection of allogeneic islet grafts -- Anti-CD20 treatment prolongs syngeneic islet graft survival and delays the onset of recurrent autoimmune diabetes -- Autologous hematopoietic stem cell transplantation for type 1 diabetes -- Time course of islet loss after intraportal transplantation -- Human regulatory CD8 T cells -- Type 1 diabetes versus type 2 diabetes with onset in persons younger than 20 years of age -- Conserved epitopes in the protein tyrosine phosphatase family of diabetes autoantigens -- Humoral immune response to islet autoantigens in Japanese patients with type 1 diabetes -- Identification of a major humoral epitope in Slc30A8 (ZnT8) -- SlC30A8 is a major target of humoral autoimmunity in type 1 diabetes and a predictive marker in prediabetes -- Prevalence of organ-specific autoantibodies in childhood- and adult-onset type 1 diabetes -- Carboxypeptidase-H autoantibodies differentiate a more latent subset of autoimmune diabetes from phenotypic type 2 diabetes among Chinese adults -- Latent autoimmune diabetes in an adult -- The sentinel role of CD8 T cells in regulating CD4 T cell responses to proinsulin in beta-islet cell autoimmunity -- Diverse foxp3 expression in children with type 1 diabetes and celiac disease -- Autoreactive T cell response in CD25-negative fraction of peripheral blood mononuclear cells in established type 1 diabetes -- Gene expression profiles stratified according to type 1 diabetes mellitus susceptibility regions -- Evaluation of cytokine production from peripheral blood mononuclear cells of type 1 diabetic patients -- Insulitis in human type 1 diabetes -- Immunoregulatory pathways controlling progression of autoimmunity in NOD mice -- Induction of apoptosis of Beta cells of the pancreas by advanced glycation end-products, important mediators of chronic complications of diabetes mellitus -- Preparation and testing of diabetes autoantibody controls -- Tumor necrosis factor alpha inducing spatial interactions between calcium-sensing receptor and L-type voltage-dependent calcium channel -- Tracking down immune markers from alternative system pathway factors in a diabetic population. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Diabetes |
| General subdivision |
Immunological aspects |
| Form subdivision |
Congresses. |
| 9 (RLIN) |
4208 |
|
|---|
| Topical term or geographic name as entry element |
Immunogenetics |
| Form subdivision |
Congresses. |
| 9 (RLIN) |
4209 |
|
|---|
| Topical term or geographic name as entry element |
Diabetes Mellitus, Type 1 |
| General subdivision |
immunology. |
| 9 (RLIN) |
4211 |
|
|---|
| 9 (RLIN) |
4210 |
| Topical term or geographic name as entry element |
Diabetes Mellitus, Type 1. |
| Form subdivision |
Congresses |
| 653 1# - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Immunology |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Sanjeevi, C. B. |
| 9 (RLIN) |
4212 |
| Relator term |
editor |
|
|---|
| Personal name |
Schatz, Desmond A. |
| 9 (RLIN) |
4213 |
| Relator term |
editor |
|
|---|
| Personal name |
Atkinson, Mark, |
| Dates associated with a name |
1961- |
| 9 (RLIN) |
4214 |
| Relator term |
editor |
| 856 42 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Publisher description |
| Uniform Resource Identifier |
http://www.loc.gov/catdir/enhancements/fy0904/2008041547-d.html |
|
|---|
| Materials specified |
Table of contents only |
| Uniform Resource Identifier |
http://www.loc.gov/catdir/enhancements/fy0904/2008041547-t.html |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Item type |
Book |
